141699-66-3

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-diMethylethyl ester
• Synonyms: 1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-diMethylethyl ester;1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-diMethylethyl este;tert-Butyl 4-(acetylsulfanyl)piperidine-1-carboxylate
• CAS NO: 141699-66-3
• Molecular Formula: C12H21NO3S
• Molecular Weight: 259.36504
• Mol File: 141699-66-3.mol
• Article Data: 25

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-diMethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-diMethylethyl ester(141699-66-3)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-diMethylethyl ester(141699-66-3)

Safety Data

• Hazardous Substances Data: 141699-66-3(Hazardous Substances Data)

Usage

General Description

1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-dimethylethyl ester is a chemical compound commonly known as tert-Butyl 4-(acetylthio)piperidine-1-carboxylate. It is often used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 1-Piperidinecarboxylic acid, 4-(acetylthio)-, 1,1-dimethylethyl ester is a tert-butyl ester derivative of 4-(acetylthio)piperidine-1-carboxylic acid, and it is commonly used in organic synthesis as a building block in the preparation of various bioactive compounds. Its unique chemical structure and properties make it a valuable building block in the development of new drugs and chemicals for various applications.

Upstream product

• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 10387-40-3 potassium thioacetate 
• 124-63-0 methanesulfonyl chloride 
• 54288-70-9 4-bromopiperidine hydrobromide 
• 24424-99-5 di-tert-butyl dicarbonate 
• 507-09-5 tiolacetic acid 
• 180695-79-8 tert-butyl 4-bromo-1-piperidinecarboxylate 
• 34832-35-4 sodium thioacetate 
• 141699-59-4 1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate 
• 118811-07-7 tert-butyl 4-(tosyloxy)piperidin-1-carboxylate 
• 189205-49-0 4-methanesulfonylpiperidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 134464-79-2 tert-butyl 4-mercapto-1-piperidinecarboxylate 

Relevant articles and documents

BORON CONTAINING COMPOUNDS AND THEIR USES

The present disclosure contemplates novel boron-containing compounds and their uses as active agents that exhibit pesticidal activity such as antimicrobial, insecticidal, arachnicidal, and/or anti parasitic activity. An agrochemical composition containing such a compound and its use in, animal health, agriculture, or horticulture is also contemplated. A method for promoting plant performance and/or controlling, reducing, preventing, ameliorating, or inhibiting microbes, insects, arachnids, and/or parasites on or in an animal, a plant, a plant part, plant propagation material, and/or harvested fruits or vegetables is also contemplated.

QUINAZOLINONES AS PARP14 INHIBITORS

The present invention relates to quinazolinones and related compounds which are inhibitors of PARP14 and are useful, for example, in the treatment of cancer and inflammatory diseases.

12-EPI PLEUROMUTILINS

A compound selected from 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteoroaryl-, or aryl)-sulfanyl)-acetyl]-12-epi-mutilins, or 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteoroaryl-, or aryl)-oxy)-acetyl]-12-epi-mutilins, wherein 12-epi-mutilin is characterized in that the mutilin ring at position 12 is substituted by two substituents, the first substituent at position 12 of the mutilin ring is a methyl group which methyl group has the inverse stereochemistry compared with the stereochemistry of the methyl group at position 12 of the naturally occurring pleuromutilin ring, the second substituent at position 12 of the mutilin ring is a hydrocarbon group comprising at least one nitrogen atom and all other substituents of the mutilin ring having the same stereochemistry compared with the stereochemistry of the substituents at the corresponding positions in the naturally occurring pleuromutilin ring; optionally in the form of a salt and/or solvate, wherein the naturally occurring pleuromutilin is of formula processes for the preparation of such compounds and their use as pharmaceuticals.